Dietary Supplementation with S-Adenosyl Methionine Delayed Amyloid-β and Tau Pathology in 3xTg-AD Mice

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Alzheimer's Disease

• Publication date

  2012-01-25

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3233/JAD-2011-111025PMID 22045486
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intraneuronal APP, Not Free Aβ Peptides in 3xTg-AD Mice: Implications for Tau versus Aβ-Mediated Alzheimer Neurodegeneration

  2011cited by this paper
• Caspase activation precedes and leads to tangles

  2010cited by this paper
• SDS-PAGE/immunoblot detection of Abeta multimers in human cortical tissue homogenates using antigen-epitope retrieval.

  2010cited by this paper
• A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia

  2010cited by this paper
• Staging of Alzheimer's Pathology in Triple Transgenic Mice: A Light and Electron Microscopic Analysis

  2010cited by this paper
• Efficacy of a Vitamin/Nutriceutical Formulation for Moderate-stage to Later-stage Alzheimer's disease: A Placebo-controlled Pilot Study

  2009cited by this paper
• Epigenetics, oxidative stress, and Alzheimer disease.

  2009cited by this paper
• Dietary deficiency increases presenilin expression, gamma‐secretase activity, and Abeta levels: potentiation by ApoE genotype and alleviation by S‐adenosyl methionine

  2009influential reference
• Mutant Presenilin 1 Increases the Expression and Activity of BACE1*

  2009cited by this paper
• Dietary Deficiency in Folate and Vitamin E Under Conditions of Oxidative Stress Increases Phospho-Tau Levels: Potentiation by ApoE4 and Alleviation by S-Adenosylmethionine

  2009influential reference
• Caspase cleavage of the amyloid precursor protein is prevented after overexpression of bcl-2 in a triple transgenic mouse model of Alzheimer's disease.

  2009cited by this paper
• The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics

  2009cited by this paper
• Efficacy of a Vitamin/Nutriceutical Formulation for Early-stage Alzheimer's Disease: A 1-year, Open-label Pilot Study With an 16-Month Caregiver Extension

  2009cited by this paper
• Dietary and genetic compromise in folate availability reduces acetylcholine, cognitive performance and increases aggression: Critical role of S-adenosyl methionine

  2008influential reference
• A Neuronal Microtubule-Interacting Agent, NAPVSIPQ, Reduces Tau Pathology and Enhances Cognitive Function in a Mouse Model of Alzheimer's Disease

  2008cited by this paper
• S-Adenosylmethionine Mediates Glutathione Efficacy by Increasing Glutathione S-Transferase Activity: Implications for S-Adenosyl Methionine as A Neuroprotective Dietary Supplement

  2008cited by this paper
• The catalytic core of gamma-secretase: presenilin revisited.

  2008cited by this paper
• S-Adenosyl Methionine: A Natural Therapeutic Agent Effective Against Multiple Hallmarks and Risk Factors Associated with Alzheimer's Disease

  2008cited by this paper
• Folate deprivation increases tau phosphorylation by homocysteine-induced calcium influx and by inhibition of phosphatase activity: Alleviation by S-adenosyl methionine.

  2008influential reference
• Detailed immunohistochemical characterization of temporal and spatial progression of Alzheimer's disease-related pathologies in male triple-transgenic mice

  2008cited by this paper
• Blocking Aβ42 Accumulation Delays the Onset and Progression of Tau Pathology via the C Terminus of Heat Shock Protein70-Interacting Protein: A Mechanistic Link between Aβ and Tau Pathology

  2008influential reference
• Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease.

  2008cited by this paper
• Effects of Dietary Supplementation with N-Acetyl Cysteine, Acetyl-l-Carnitine and S-Adenosyl Methionine on Cognitive Performance and Aggression in Normal Mice and Mice Expressing Human ApoE4

  2008cited by this paper
• Causes of oxidative stress in Alzheimer disease

  2007cited by this paper
• Effects of Dietary Supplementation with N-Acetyl Cysteine, Acetyl-l-Carnitine and S-Adenosyl Methionine on Cognitive Performance and Aggression in Normal Mice and Mice Expressing Human ApoE4

  2007cited by this paper
• Folate deprivation increases presenilin expression, gamma‐secretase activity, and Abeta levels in murine brain: potentiation by ApoE deficiency and alleviation by dietary S‐adenosyl methionine

  2007influential reference
• Genetically augmenting tau levels does not modulate the onset or progression of Aβ pathology in transgenic mice

  2007cited by this paper
• Protein Phosphatase 2A Methyltransferase Links Homocysteine Metabolism with Tau and Amyloid Precursor Protein Regulation

  2007cited by this paper
• Dietary supplementation with 3-deaza adenosine, N-acetyl cysteine, and S-adenosyl methionine provide neuroprotection against multiple consequences of vitamin deficiency and oxidative challenge

  2007cited by this paper
• Temporal Profile of Amyloid-β (Aβ) Oligomerization in an in Vivo Model of Alzheimer Disease

  2006cited by this paper
• Reduction of Soluble Aβ and Tau, but Not Soluble Aβ Alone, Ameliorates Cognitive Decline in Transgenic Mice with Plaques and Tangles*

  2006cited by this paper
• A vicious circle: role of oxidative stress, intraneuronal Abeta and Cu in Alzheimer's disease.

  2006cited by this paper
• Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology.

  2006cited by this paper
• Expression and activity of methionine cycle genes are altered following folate and vitamin E deficiency under oxidative challenge: Modulation by apolipoprotein E-deficiency

  2006cited by this paper
• Filling the gaps in the abeta cascade hypothesis of Alzheimer's disease.

  2006cited by this paper
• Dietary and genetically-induced oxidative stress alter tau phosphorylation: Influence of folate and apolipoprotein E deficiency

  2006cited by this paper
• Filling the Gaps in the Aβ Cascade Hypothesis of Alzheimers Disease

  2006cited by this paper
• Tau truncation during neurofibrillary tangle evolution in Alzheimer's disease.

  2005cited by this paper
• The Role of Caspase Cleavage of Tau in Alzheimer Disease Neuropathology

  2005cited by this paper
• N-acteyl cysteine alleviates oxidative damage to central nervous system of ApoE-deficient mice following folate and vitamin E-deficiency

  2005cited by this paper
• S-adenosylmethionine/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production.

  2005cited by this paper
• Increased transcription and activity of glutathione synthase in response to deficiencies in folate, vitamin E, and apolipoprotein E

  2004cited by this paper
• [The beta-amyloid cascade hypothesis: a sequence of events leading to neurodegeneration in Alzheimer's disease].

  2004cited by this paper
• Alzheimer's disease pathogenesis and therapeutic interventions.

  2004cited by this paper
• Elevated S-adenosylhomocysteine in Alzheimer brain: influence on methyltransferases and cognitive function

  2004cited by this paper
• Oxidative stress signalling in Alzheimer's disease.

  2004cited by this paper
• Molecular Genetics of Late‐Onset Alzheimer's Disease

  2004cited by this paper
• Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease.

  2003cited by this paper
• Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction.

  2003influential reference
• Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease

  2003influential reference
• Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders.

  2003cited by this paper
• Comparative Analysis of an Improved Thioflavin-S Stain, Gallyas Silver Stain, and Immunohistochemistry for Neurofibrillary Tangle Demonstration on the Same Sections

  2002cited by this paper
• The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

  2002cited by this paper
• S-Adenosyl-L-methionine (SAMe): from the bench to the bedside--molecular basis of a pleiotrophic molecule.

  2002cited by this paper
• S-Adenosylmethionine: molecular, biological, and clinical aspects--an introduction.

  2002cited by this paper
• Tau and transgenic animal models.

  2001cited by this paper
• Alzheimer's disease: genes, proteins, and therapy.

  2001cited by this paper
• Correlation Between Aβx-40–, Aβx-42–, and Aβx-43–Containing Amyloid Plaques and Cognitive Decline

  2001cited by this paper
• Correlation between Abetax-40-, Abetax-42-, and Abetax-43-containing amyloid plaques and cognitive decline.

  2001cited by this paper
• S-Adenosylmethionine.

  2000cited by this paper
• B vitamins, homocysteine, and neurocognitive function in the elderly.

  2000cited by this paper
• Genes and mechanisms involved in β-amyloid generation and Alzheimer’s disease

  1999cited by this paper
• Genes and mechanisms involved in beta-amyloid generation and Alzheimer's disease.

  1999cited by this paper
• Decreased in vivo protein and phospholipid methylation after in vivo elevation of brain S-adenosyl-homocysteine.

  1981cited by this paper

• DNA methylation and the APP gene: dietary influences in the context of Alzheimer’s disease—a mini review

  2026cites this paper
• Epigenetic mechanisms of HIV and opioid-induced neuropathology: Potential therapies and interventions

  2025cites this paper
• Reversing Epigenetic Dysregulation in Neurodegenerative Diseases: Mechanistic and Therapeutic Considerations

  2025cites this paper
• Exercise and the Organ-Brain Axis: Regulation of Neurological Disorders by Emerging Exerkines.

  2025cites this paper
• Exercise mimetics: a novel strategy to combat neuroinflammation and Alzheimer’s disease

  2024influential citation
• Can L-Methionine and S-Adenosyl-L-Methionine Effectively Mitigate Scopolamine-Induced Cognitive and Motor Deficits in Mice?

  2024cites this paper
• Associations between dietary one-carbon metabolism nutrients, genetic risk, with Alzheimer's disease: a prospective cohort study.

  2024cites this paper
• Can exercise benefits be harnessed with drugs? A new way to combat neurodegenerative diseases by boosting neurogenesis

  2024influential citation
• Methyl donor supplementation reduces phospho‐Tau, Fyn and demethylated protein phosphatase 2A levels and mitigates learning and motor deficits in a mouse model of tauopathy

  2023cites this paper
• BACE1 and SCD1 are associated with neurodegeneration

  2023cites this paper
• Protocol of a Phase II Randomized, Multi-Center, Double-Blind, Placebo-Controlled Trial of S-Adenosyl Methionine in Participants with Mild Cognitive Impairment or Dementia Due to Alzheimer’s Disease

  2023cites this paper
• Effects of Methionine treatment on epigenetic regulation of the 5-HT neurotransmission in 5xFAD mouse model of Alzheimer’s disease

  2022cites this paper
• Gene–environment interactions in Alzheimer disease: the emerging role of epigenetics

  2022cites this paper
• Metabolic disorder in Alzheimer’s disease

  2021cites this paper
• Improvement of cognitive performance by a nutraceutical formulation: Underlying mechanisms revealed by laboratory studies.

  2021cites this paper
• Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer’s disease

  2021cites this paper
• Evidence to Support the Use of S-Adenosylmethionine for Treatment of Post-Concussive Sequelae in the Military.

  2021cites this paper
• Epigenetic regulation in Alzheimer’s disease: is it a potential therapeutic target?

  2021cites this paper
• Neuroprotective Roles of the Reverse Transsulfuration Pathway in Alzheimer’s Disease

  2021cites this paper
• Epigenetics of the Developing and Aging Brain: Mechanisms that Regulate Onset and Outcomes of Brain Reorganization.

  2021cites this paper
• S-Adenosylmethionine Rescues Cognitive Deficits in the rTg4510 Animal Model by Stabilizing Protein Phosphatase 2A and Reducing Phosphorylated Tau

  2020cites this paper
• S-Adenosylmethionine Alleviates Amyloid-β-Induced Neural Injury by Enhancing Trans-Sulfuration Pathway Activity in Astrocytes

  2020cites this paper
• A diet rich in taurine, cysteine, folate, B12 and betaine may lessen risk for Alzheimer's disease by boosting brain synthesis of hydrogen sulfide.

  2019cites this paper
• Epigenetic regulation of astrocyte function in neuroinflammation and neurodegeneration.

  2018cites this paper
• Neuroepigenetics of Aging and Age-Related Neurodegenerative Disorders.

  2018cites this paper
• S-Adenosyl Methionine and Transmethylation Pathways in Neuropsychiatric Diseases Throughout Life

  2018cites this paper
• Nutritional interventions and cognitive‐related outcomes in patients with late‐life cognitive disorders: A systematic review

  2018cites this paper
• S-Adenosylmethionine Metabolism and Aging

  2018cites this paper
• 5 Integrative NutritionSupplements

  2017cites this paper
• While I Still Remember: 30 Years of Alzheimer’s Disease Research

  2017cites this paper
• S-Adenosyl Methionine in the Therapy of Depression and Other Psychiatric Disorders

  2016cites this paper
• Epigenetic Advancements in Cancer

  2016cites this paper
• Genetic architecture for human aggression: A study of gene–phenotype relationship in OMIM

  2016cites this paper
• Traumatic Brain Injury Alters Methionine Metabolism: Implications for Pathophysiology

  2016cites this paper
• Rescue of Early bace-1 and Global DNA Demethylation by S-Adenosylmethionine Reduces Amyloid Pathology and Improves Cognition in an Alzheimer’s Model

  2016cites this paper
• Folic acid attenuates the effects of amyloid β oligomers on DNA methylation in neuronal cells

  2016cites this paper
• Maintenance of Cognitive Performance and Mood for Individuals with Alzheimer's Disease Following Consumption of a Nutraceutical Formulation: A One-Year, Open-Label Study.

  2016cites this paper
• S‐Adenosyl Methionine in the Therapy of Depression and Other Psychiatric Disorders

  2016cites this paper
• DNA Methylation in Cellular Mechanisms of Neurodegeneration

  2016cites this paper
• Epigenetic Post transcriptional Mutation in Neuro-Oncology

  2016cites this paper
• Nutritional approaches to mitigating cognitive decline and maintaining function in Alzheimer's disease: Transgenic mouse models, combinatorial approaches and dietary supplementation with folate and S-adenosyl methionine

  2015cites this paper
• A Phase II Randomized Clinical Trial of a Nutritional Formulation for Cognition and Mood in Alzheimer's Disease

  2015cites this paper
• The epigenetics of aging and neurodegeneration.

  2015cites this paper
• Integrative Nutrition: Supplements

  2015cites this paper
• Pharmacological methyl group donors block skeletal metastasis in vitro and in vivo

  2015cites this paper
• A Nutritional Formulation for Cognitive Performance in Mild Cognitive Impairment: A Placebo-Controlled Trial with an Open-Label Extension

  2015cites this paper
• Folic acid administration inhibits amyloid β-peptide accumulation in APP/PS1 transgenic mice.

  2015cites this paper
• Epigenetics, a key for unlocking complex CNS disorders? Therapeutic implications.

  2015influential citation
• Prospects for the development of epigenetic drugs for CNS conditions

  2015cites this paper
• Nutritional supplementation for Alzheimer's disease?

  2015cites this paper
• Alzheimer’s Disease: Current Perspectives – Animal Models, Drugs Under Development, and Potential Nutritional Intervention

  2015cites this paper
• Has Prenatal Folate Supplementation Established an At-Risk Population for Age-Related Cognitive Decline?

  2014cites this paper
• Novel therapeutic targets in neuropsychiatric disorders: the neuroepigenome.

  2014cites this paper
• The potential of epigenetic therapies in neurodegenerative diseases

  2014cites this paper
• Lifetime requirement of the methionine cycle for neuronal development and maintenance

  2014cites this paper
• Genetic mouse models of brain ageing and Alzheimer's disease.

  2014cites this paper
• Alzheimer's Disease and Methanol Toxicity (Part 1): Chronic Methanol Feeding Led to Memory Impairments and Tau Hyperphosphorylation in Mice

  2014cites this paper
• Role of the PduL enzyme in the function of primitive bacterial organelles found in Salmonella

  2014cites this paper
• Epigenetic Signature of Chronic Cerebral Hypoperfusion and Beneficial Effects of S-adenosylmethionine in Rats

  2014cites this paper
• Epigenetic drug discovery for Alzheimer’s disease

  2014cites this paper
• Epigenetic Features Induced by Ischemia-Hypoxia in Cultured Rat Astrocytes

  2014cites this paper
• Influence of food restriction on mammalian immunity

  2013cites this paper
• Rapid, Reversible Impairment of Synaptic Signaling in Cultured Cortical Neurons by Exogenously-Applied Amyloid-β

  2013cites this paper
• Autophagy Modulation for Alzheimer’s Disease Therapy

  2013cites this paper
• Homocysteine and Parkinsons Disease: A Complex Relationship

  2013cites this paper
• Positive argument for debate in J Neural Transmission: Alzheimer’s disease: are we intervening too late? Yes, by years if not decades

  2012cites this paper
• rug pipeline in neurodegeneration based on transgenic mice models of lzheimer ’ s disease

  2012cites this paper
• Nutrition and Dementia: Are we Asking the Right Questions?

  2012cites this paper
• Age Related Changes in Cognition and Brain: A Focus on Progestogens

  2012cites this paper
• Broad-Based Nutritional Supplementation in 3xTg Mice Corrects Mitochondrial Function and Indicates Sex-Specificity in Response to Alzheimer's Disease Intervention

  2012cites this paper